sq-11725 has been researched along with linoleic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Reish, IA; Aljada, A; Bapna, V; Dandona, P; Ghanim, H; Hamouda, W; Magsino, CH | 1 |
1 trial(s) available for sq-11725 and linoleic acid
| Article | Year |
|---|---|
Nadolol inhibits reactive oxygen species generation by leukocytes and linoleic acid oxidation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Chromatography, High Pressure Liquid; Female; Humans; Leukocytes, Mononuclear; Linoleic Acid; Male; Nadolol; Neutrophils; Oxidation-Reduction; Phenylalanine; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Tyrosine | 2000 |